Symbols / ANGO
ANGO Chart
About
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Instruments & Su | Market Cap | 444.32M |
| Enterprise Value | 414.48M | Income | -27.71M | Sales | 307.31M |
| Book/sh | 4.24 | Cash/sh | 1.01 | Dividend Yield | — |
| Payout | 0.00% | Employees | 675 | IPO | — |
| P/E | — | Forward P/E | -98.00 | PEG | — |
| P/S | 1.45 | P/B | 2.54 | P/C | — |
| EV/EBITDA | -2763.17 | EV/Sales | 1.35 | Quick Ratio | 1.20 |
| Current Ratio | 2.24 | Debt/Eq | 6.69 | LT Debt/Eq | — |
| EPS (ttm) | -0.67 | EPS next Y | -0.11 | EPS Growth | — |
| Revenue Growth | 9.00% | Earnings | 2026-04-02 | ROA | -4.60% |
| ROE | -15.26% | ROIC | — | Gross Margin | 54.58% |
| Oper. Margin | -3.14% | Profit Margin | -9.02% | Shs Outstand | 41.22M |
| Shs Float | 33.09M | Short Float | 4.39% | Short Ratio | 3.17 |
| Short Interest | — | 52W High | 13.99 | 52W Low | 8.27 |
| Beta | 0.45 | Avg Volume | 555.38K | Volume | 257.69K |
| Target Price | $19.33 | Recom | None | Prev Close | $10.83 |
| Price | $10.78 | Change | -0.46% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$19.33
Mean price target
2. Current target
$10.78
Latest analyst target
3. DCF / Fair value
$0.13
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.78
Low
$16.00
High
$24.00
Mean
$19.33
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-10-03 | main | Canaccord Genuity | Buy → Buy | $18 |
| 2025-07-16 | init | Lake Street | — → Buy | $24 |
| 2025-07-16 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2025-07-16 | main | Canaccord Genuity | Buy → Buy | $17 |
| 2025-04-07 | main | HC Wainwright & Co. | Buy → Buy | $16 |
| 2025-01-10 | main | HC Wainwright & Co. | Buy → Buy | $15 |
| 2025-01-09 | main | Canaccord Genuity | Buy → Buy | $15 |
| 2024-12-10 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-10-04 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-10-04 | main | Canaccord Genuity | Buy → Buy | $12 |
| 2024-09-20 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-07-17 | main | Canaccord Genuity | Buy → Buy | $13 |
| 2024-07-17 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-05-22 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-04-05 | up | Oppenheimer | Perform → Outperform | $12 |
| 2024-01-09 | main | Raymond James | Outperform → Outperform | $10 |
| 2024-01-08 | main | HC Wainwright & Co. | Buy → Buy | $18 |
| 2023-10-06 | main | Raymond James | Outperform → Outperform | $12 |
| 2023-10-05 | main | Canaccord Genuity | Buy → Buy | $17 |
| 2023-10-05 | main | HC Wainwright & Co. | Buy → Buy | $20 |
- How Angiodynamics Inc. (ANGO) Affects Rotational Strategy Timing - Stock Traders Daily Fri, 06 Mar 2026 06
- Hear AngioDynamics CEO Jim Clemmer live at Leerink healthcare conference - Stock Titan Mon, 23 Feb 2026 08
- AngioDynamics Stock (ANGO) Opinions on CEO Share Purchase - Quiver Quantitative Fri, 10 Oct 2025 07
- ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves - Nasdaq Wed, 07 Jan 2026 08
- Why AngioDynamics Stock Is Sinking Today - The Motley Fool ue, 06 Jan 2026 08
- ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation - Zacks Investment Research Mon, 23 Feb 2026 08
- Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance Fri, 30 Jan 2026 08
- ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - Nasdaq Fri, 03 Oct 2025 07
- AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance hu, 02 Oct 2025 07
- New tumor option in liver, pancreas, kidney as NanoKnife use widens in Europe - Stock Titan hu, 19 Feb 2026 08
- $ANGO stock is down 15% today. Here's what we see in our data. - Quiver Quantitative ue, 06 Jan 2026 08
- Why Did AngioDynamics Stock Pop Today? - The Motley Fool hu, 02 Oct 2025 07
- RGTI Stock Down Despite Q4 Earnings Top Estimates, Revenues Decline Y/Y - Zacks Investment Research hu, 05 Mar 2026 13
- Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance Wed, 01 Oct 2025 07
- ANGIODYNAMICS Q2 2026 Earnings Preview: Recent $ANGO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative Sun, 04 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 10000 | 118100.0 | — | Purchase at price 11.81 per share. | LAWRENCE WEISS T | Officer | — | 2025-10-21 00:00:00 | D |
| 1 | 890 | 9932.0 | — | Purchase at price 11.16 per share. | TROWBRIDGE STEPHEN A | Chief Financial Officer | — | 2025-10-13 00:00:00 | D |
| 2 | 10000 | 111500.0 | — | Purchase at price 11.15 per share. | CLEMMER JAMES C | Chief Executive Officer | — | 2025-10-09 00:00:00 | D |
| 3 | 30900 | — | — | Stock Award(Grant) at price 0.00 per share. | LAWRENCE WEISS T | Officer | — | 2025-07-16 00:00:00 | D |
| 4 | 17675 | — | — | Stock Award(Grant) at price 0.00 per share. | JOHNSON WESLEY E JR | Director | — | 2025-07-16 00:00:00 | D |
| 5 | 17675 | — | — | Stock Award(Grant) at price 0.00 per share. | AUEN EILEEN O SHEA | Director | — | 2025-07-16 00:00:00 | D |
| 6 | 17675 | — | — | Stock Award(Grant) at price 0.00 per share. | REED JAN STERN J.D. | Director | — | 2025-07-16 00:00:00 | D |
| 7 | 17675 | — | — | Stock Award(Grant) at price 0.00 per share. | DONNELLY HOWARD W | Director | — | 2025-07-16 00:00:00 | D |
| 8 | 206253 | — | — | Stock Award(Grant) at price 0.00 per share. | CLEMMER JAMES C | Chief Executive Officer | — | 2025-07-16 00:00:00 | D |
| 9 | 29349 | — | — | Stock Award(Grant) at price 0.00 per share. | NIGHAN WARREN G JR | Officer | — | 2025-07-16 00:00:00 | D |
Financials
| Line Item | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -15.89K | -6.03M | -1.19M | -1.16M |
| TaxRateForCalcs | 0.00 | 0.04 | 0.04 | 0.11 |
| NormalizedEBITDA | 17.63M | 152.46M | 44.70M | 21.39M |
| TotalUnusualItems | -15.89M | -158.59M | -32.50M | -10.25M |
| TotalUnusualItemsExcludingGoodwill | -15.89M | -158.59M | -32.50M | -10.25M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -33.99M | -184.35M | -52.44M | -26.55M |
| ReconciledDepreciation | 25.80M | 27.71M | 30.87M | 29.35M |
| ReconciledCostOfRevenue | 119.31M | 134.55M | 152.42M | 140.60M |
| EBITDA | 1.74M | -6.13M | 12.19M | 11.13M |
| EBIT | -24.06M | -33.84M | -18.68M | -18.22M |
| NetInterestIncome | 978.00K | 1.61M | -2.70M | -688.00K |
| InterestExpense | 2.70M | 688.00K | 861.00K | |
| NormalizedIncome | -18.12M | -31.78M | -21.13M | -17.46M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -33.99M | -184.35M | -52.44M | -26.55M |
| TotalExpenses | 316.56M | 337.76M | 357.43M | 334.44M |
| TotalOperatingIncomeAsReported | -39.95M | -192.44M | -51.18M | -28.47M |
| DilutedAverageShares | 40.85M | 40.18M | 39.48M | 39.01M |
| BasicAverageShares | 40.85M | 40.18M | 39.48M | 39.01M |
| DilutedEPS | -0.83 | -4.59 | -1.33 | -0.68 |
| BasicEPS | -0.83 | -4.59 | -1.33 | -0.68 |
| DilutedNIAvailtoComStockholders | -33.99M | -184.35M | -52.44M | -26.55M |
| NetIncomeCommonStockholders | -33.99M | -184.35M | -52.44M | -26.55M |
| NetIncome | -33.99M | -184.35M | -52.44M | -26.55M |
| NetIncomeIncludingNoncontrollingInterests | -33.99M | -184.35M | -52.44M | -26.55M |
| NetIncomeDiscontinuousOperations | 0.00 | |||
| NetIncomeContinuousOperations | -33.99M | -184.35M | -52.44M | -26.55M |
| TaxProvision | -39.00K | -7.29M | -2.00M | -3.40M |
| PretaxIncome | -34.03M | -191.64M | -54.44M | -29.95M |
| OtherIncomeExpense | -10.95M | -159.41M | -33.06M | -11.04M |
| OtherNonOperatingIncomeExpenses | 4.94M | -817.00K | -554.00K | -790.00K |
| SpecialIncomeCharges | -15.89M | -158.59M | -32.50M | -10.25M |
| GainOnSaleOfPPE | 0.00 | 54.50M | 0.00 | 0.00 |
| GainOnSaleOfBusiness | 0.00 | 0.00 | 1.03M | |
| OtherSpecialCharges | 715.00K | 34.94M | 10.00M | 7.62M |
| ImpairmentOfCapitalAssets | 0.00 | 165.74M | 14.55M | 0.00 |
| RestructuringAndMergernAcquisition | 15.18M | 12.41M | 7.96M | 2.63M |
| NetNonOperatingInterestIncomeExpense | 978.00K | 1.61M | -2.70M | -688.00K |
| TotalOtherFinanceCost | -978.00K | -1.61M | 2.70M | 688.00K |
| InterestExpenseNonOperating | 2.70M | 688.00K | 861.00K | |
| OperatingIncome | -24.06M | -33.84M | -18.68M | -18.22M |
| OperatingExpense | 181.77M | 188.54M | 192.93M | 183.95M |
| DepreciationAmortizationDepletionIncomeStatement | 10.32M | 13.05M | 18.79M | 19.46M |
| DepreciationAndAmortizationInIncomeStatement | 10.32M | 13.05M | 18.79M | 19.46M |
| Amortization | 10.32M | 13.05M | 18.79M | 19.46M |
| AmortizationOfIntangiblesIncomeStatement | 10.32M | 13.05M | 18.79M | 19.46M |
| ResearchAndDevelopment | 26.22M | 31.51M | 29.88M | 30.74M |
| SellingGeneralAndAdministration | 145.23M | 143.98M | 144.25M | 133.75M |
| SellingAndMarketingExpense | 103.14M | 102.82M | 104.25M | 95.30M |
| GeneralAndAdministrativeExpense | 42.09M | 41.16M | 40.00M | 38.45M |
| OtherGandA | 42.09M | 41.16M | 40.00M | 38.45M |
| GrossProfit | 157.71M | 154.70M | 174.25M | 165.73M |
| CostOfRevenue | 134.79M | 149.22M | 164.51M | 150.49M |
| TotalRevenue | 292.50M | 303.91M | 338.75M | 316.22M |
| OperatingRevenue | 292.50M | 303.91M | 338.75M | 316.22M |
| Line Item | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 613.85K | 370.00K | 370.00K | 370.00K |
| OrdinarySharesNumber | 40.99M | 40.43M | 39.61M | 39.17M |
| ShareIssued | 41.61M | 40.80M | 39.98M | 39.54M |
| NetDebt | 19.96M | 4.96M | ||
| TotalDebt | 4.73M | 64.58M | 33.78M | 20.00M |
| TangibleBookValue | 113.85M | 128.20M | 107.91M | 71.05M |
| InvestedCapital | 182.97M | 210.31M | 442.88M | 458.27M |
| WorkingCapital | 92.13M | 102.10M | 79.72M | 69.02M |
| NetTangibleAssets | 113.85M | 128.20M | 107.91M | 71.05M |
| CommonStockEquity | 182.97M | 205.59M | 378.30M | 424.49M |
| TotalCapitalization | 182.97M | 205.59M | 428.11M | 449.49M |
| TotalEquityGrossMinorityInterest | 182.97M | 205.59M | 378.30M | 424.49M |
| StockholdersEquity | 182.97M | 205.59M | 378.30M | 424.49M |
| GainsLossesNotAffectingRetainedEarnings | -2.02M | -4.37M | -4.72M | 1.36M |
| OtherEquityAdjustments | -2.02M | -4.37M | -4.72M | 1.36M |
| TreasuryStock | 7.38M | 5.71M | 5.71M | 5.71M |
| RetainedEarnings | -429.20M | -395.20M | -210.85M | -158.41M |
| AdditionalPaidInCapital | 621.19M | 610.48M | 599.21M | 586.88M |
| CapitalStock | 385.00K | 385.00K | 382.00K | 380.00K |
| CommonStock | 385.00K | 385.00K | 382.00K | 380.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 97.17M | 112.08M | 154.34M | 128.26M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 20.98M | 20.93M | 70.52M | 53.94M |
| OtherNonCurrentLiabilities | 16.90M | 16.08M | 7.88M | 12.90M |
| NonCurrentDeferredLiabilities | 4.07M | 4.85M | 12.81M | 16.04M |
| NonCurrentDeferredTaxesLiabilities | 4.07M | 4.85M | 12.81M | 16.04M |
| LongTermDebtAndCapitalLeaseObligation | 49.82M | 25.00M | 20.00M | |
| LongTermDebt | 49.82M | 25.00M | 20.00M | |
| CurrentLiabilities | 76.20M | 91.16M | 83.83M | 74.32M |
| OtherCurrentLiabilities | 7.39M | 7.58M | 2.00M | 2.65M |
| CurrentDeferredLiabilities | 374.00K | 0.00 | ||
| CurrentDebtAndCapitalLeaseObligation | 4.73M | 14.76M | 8.78M | |
| CurrentDebt | 4.73M | 14.76M | 8.78M | |
| OtherCurrentBorrowings | 4.73M | 14.76M | 8.78M | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 800.00K | 1.49M | 262.00K | 59.00K |
| PayablesAndAccruedExpenses | 67.64M | 77.36M | 66.80M | 62.83M |
| CurrentAccruedExpenses | 31.57M | 32.83M | 25.88M | 34.03M |
| Payables | 36.06M | 44.53M | 40.92M | 28.80M |
| OtherPayable | 2.24M | 6.26M | ||
| TotalTaxPayable | 531.00K | 520.00K | 480.00K | 750.00K |
| AccountsPayable | 33.29M | 37.75M | 40.45M | 28.05M |
| TotalAssets | 280.14M | 317.67M | 532.64M | 552.75M |
| TotalNonCurrentAssets | 111.82M | 124.42M | 369.10M | 409.41M |
| OtherNonCurrentAssets | 10.40M | 11.37M | 54.33M | 10.96M |
| GoodwillAndOtherIntangibleAssets | 69.12M | 77.38M | 270.38M | 353.44M |
| OtherIntangibleAssets | 69.12M | 77.38M | 111.14M | 152.38M |
| Goodwill | 0.00 | 159.24M | 201.06M | 201.32M |
| NetPPE | 32.30M | 35.67M | 44.38M | 45.01M |
| AccumulatedDepreciation | -71.12M | -73.04M | -59.03M | -51.07M |
| GrossPPE | 103.42M | 108.70M | 103.41M | 96.07M |
| ConstructionInProgress | 3.79M | 2.64M | 2.44M | 2.40M |
| OtherProperties | 36.99M | 31.31M | 26.36M | 21.01M |
| MachineryFurnitureEquipment | 45.63M | 44.16M | 44.46M | 42.74M |
| BuildingsAndImprovements | 16.60M | 30.10M | 29.66M | 29.43M |
| LandAndImprovements | 393.00K | 493.00K | 493.00K | 493.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 168.32M | 193.25M | 163.54M | 143.34M |
| OtherCurrentAssets | 3.07M | 2.58M | 1.10M | 2.20M |
| AssetsHeldForSaleCurrent | 0.00 | 6.15M | 0.00 | |
| PrepaidAssets | 4.21M | 3.99M | 3.52M | 4.43M |
| Inventory | 62.01M | 60.62M | 55.33M | 51.39M |
| FinishedGoods | 27.00M | 23.11M | 19.94M | 15.96M |
| WorkInProcess | 7.51M | 6.77M | 6.71M | 7.19M |
| RawMaterials | 27.50M | 30.74M | 28.68M | 28.25M |
| Receivables | 43.14M | 50.01M | 52.83M | 56.50M |
| OtherReceivables | 250.00K | 6.40M | 2.00K | |
| TaxesReceivable | 0.00 | 4.19M | 1.91M | |
| AccountsReceivable | 42.89M | 43.61M | 52.83M | 52.30M |
| AllowanceForDoubtfulAccountsReceivable | -2.21M | -2.14M | -2.15M | -1.94M |
| GrossAccountsReceivable | 45.10M | 45.75M | 54.98M | 54.24M |
| CashCashEquivalentsAndShortTermInvestments | 55.89M | 76.06M | 44.62M | 28.82M |
| CashAndCashEquivalents | 55.89M | 76.06M | 44.62M | 28.82M |
| Line Item | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| FreeCashFlow | -14.59M | -33.93M | -4.27M | -11.49M |
| RepurchaseOfCapitalStock | -1.67M | 0.00 | 0.00 | |
| RepaymentOfDebt | 0.00 | -50.00M | -45.00M | 0.00 |
| IssuanceOfDebt | 0.00 | 0.00 | 70.00M | 5.00M |
| CapitalExpenditure | -4.46M | -5.77M | -4.35M | -4.30M |
| InterestPaidSupplementalData | 185.00K | 0.00 | 2.58M | 562.00K |
| IncomeTaxPaidSupplementalData | 800.00K | 455.00K | 342.00K | 329.00K |
| EndCashPosition | 55.89M | 76.06M | 44.62M | 28.82M |
| BeginningCashPosition | 76.06M | 44.62M | 28.82M | 48.16M |
| EffectOfExchangeRateChanges | 398.00K | 125.00K | 43.00K | -518.00K |
| ChangesInCash | -20.56M | 31.31M | 15.75M | -18.82M |
| FinancingCashFlow | -255.00K | -64.25M | 25.42M | 7.68M |
| CashFlowFromContinuingFinancingActivities | -255.00K | -64.25M | 25.42M | 7.68M |
| NetOtherFinancingCharges | 482.00K | -15.00M | -751.00K | |
| ProceedsFromStockOptionExercised | 933.00K | 752.00K | 1.17M | 2.68M |
| NetCommonStockIssuance | -1.67M | 0.00 | 0.00 | |
| CommonStockPayments | -1.67M | 0.00 | 0.00 | |
| NetIssuancePaymentsOfDebt | 0.00 | -50.00M | 25.00M | 5.00M |
| NetLongTermDebtIssuance | 0.00 | -50.00M | 25.00M | 5.00M |
| LongTermDebtPayments | 0.00 | -50.00M | -45.00M | 0.00 |
| LongTermDebtIssuance | 0.00 | 0.00 | 70.00M | 5.00M |
| InvestingCashFlow | -10.18M | 123.72M | -9.75M | -19.31M |
| CashFromDiscontinuedInvestingActivities | 0.00 | |||
| CashFlowFromContinuingInvestingActivities | -10.18M | 123.72M | -9.75M | -19.31M |
| NetOtherInvestingChanges | -5.71M | 129.49M | -5.39M | -11.41M |
| NetInvestmentPurchaseAndSale | 0.00 | |||
| SaleOfInvestment | 0.00 | |||
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | -3.60M | 0.00 |
| PurchaseOfBusiness | 0.00 | 0.00 | -3.60M | 0.00 |
| NetIntangiblesPurchaseAndSale | 0.00 | -3.25M | -540.00K | 0.00 |
| PurchaseOfIntangibles | 0.00 | -3.25M | -540.00K | 0.00 |
| NetPPEPurchaseAndSale | -4.46M | -2.52M | -3.81M | -4.30M |
| PurchaseOfPPE | -4.46M | -2.52M | -3.81M | -4.30M |
| OperatingCashFlow | -10.13M | -28.16M | 78.00K | -7.19M |
| CashFlowFromContinuingOperatingActivities | -10.13M | -28.16M | 78.00K | -7.19M |
| ChangeInWorkingCapital | -14.11M | 14.42M | -7.03M | -21.05M |
| ChangeInPayablesAndAccruedExpense | -15.88M | 27.53M | 2.14M | 3.91M |
| ChangeInPayable | -15.88M | 27.53M | 2.14M | 3.91M |
| ChangeInAccountPayable | -15.88M | 27.53M | 2.14M | 3.91M |
| ChangeInPrepaidAssets | 3.09M | -11.59M | 332.00K | -5.01M |
| ChangeInInventory | -1.35M | -9.41M | -8.20M | -2.80M |
| ChangeInReceivables | 23.00K | 7.89M | -1.30M | -17.15M |
| ChangesInAccountReceivables | 23.00K | 7.89M | -1.30M | -17.15M |
| OtherNonCashItems | 2.52M | -2.78M | 4.29M | 3.56M |
| StockBasedCompensation | 9.77M | 10.53M | 11.16M | 10.69M |
| ProvisionandWriteOffofAssets | 699.00K | 1.33M | 695.00K | 118.00K |
| AssetImpairmentCharge | 173.00K | 167.45M | 14.84M | 391.00K |
| DeferredTax | -988.00K | -7.97M | -2.31M | -3.71M |
| DeferredIncomeTax | -988.00K | -7.97M | -2.31M | -3.71M |
| DepreciationAmortizationDepletion | 25.80M | 27.71M | 30.87M | 29.35M |
| DepreciationAndAmortization | 25.80M | 27.71M | 30.87M | 29.35M |
| OperatingGainsLosses | -54.50M | |||
| NetIncomeFromContinuingOperations | -33.99M | -184.35M | -52.44M | -26.55M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ANGO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|